Concepedia

Christopher R. Van Besien

CR

2

Publications

145

Citations

2

H-Index

2003

Active since

Affiliations

Johnson & Johnson (United States)(Current)

Christopher R. Van Besien is an author at Johnson & Johnson (United States).

Publications per year

2003–2009

2

Publications

2

Selected Contribution: TNF-α modulates murine tracheal rings responsiveness to G-protein-coupled receptor agonists and KCl

Hang Chen, Omar Tliba, Christopher R. Van Besien et al. · Journal of Applied Physiology · 2003 · 78 citations

JNJ-20788560 [9-(8-Azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic Acid Diethylamide], a Selective Delta Opioid Receptor Agonist, Is a Potent and Efficacious Antihyperalgesic Agent That Does Not Produce Respiratory Depression, Pharmacologic Tolerance, or Physical Dependence

Ellen E. Codd, John R. Carson, Raymond W. Colburn et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 67 citations

Rows per page

1–2 of 2